XTLB
XTL Biopharmaceuticals Ltd.

1,359
Mkt Cap
$9.19M
Volume
134,128.00
52W High
$2.57
52W Low
$0.5301
PE Ratio
-8.68
XTLB Fundamentals
Price
$0.9712
Prev Close
$0.968
Open
$0.8998
50D MA
$0.828
Beta
0.51
Avg. Volume
50,246.45
EPS (Annual)
-$0.1537
P/B
1.57
Rev/Employee
$41,194.64
Loading...
Loading...
XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
11

Frequently Asked Questions

What is Market Cap of X.T.L. Biopharmaceuticals Ltd. - ADR?
What is the 52-week high for X.T.L. Biopharmaceuticals Ltd. - ADR?
What is the 52-week low for X.T.L. Biopharmaceuticals Ltd. - ADR?
What is X.T.L. Biopharmaceuticals Ltd. - ADR stock price today?
What was X.T.L. Biopharmaceuticals Ltd. - ADR stock price yesterday?
What is the PE ratio of X.T.L. Biopharmaceuticals Ltd. - ADR?
What is the Price-to-Book ratio of X.T.L. Biopharmaceuticals Ltd. - ADR?
What is the 50-day moving average of X.T.L. Biopharmaceuticals Ltd. - ADR?
How many employess does X.T.L. Biopharmaceuticals Ltd. - ADR has?

Latest XTLB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.